News - Onyx Pharmaceuticals, Markets & Marketing


Popular Filters

Onyx partners for carfilzomib managed access program in Europe


US drugmaker Onyx Pharmaceuticals (Nasdaq: ONXX) is partnering with UK-based Idis Limited to initiate…

carfilzomibEuropeIdis LimitedMarkets & MarketingOncologyOnyx PharmaceuticalsPharmaceutical

US and European hema-oncologists views therapies for relapsed/refractory multiple myeloma


US and European hematological oncologists surveyed by health care advisory firm Decision Resources indicate…

carfilzomibEuropeKyprolisMarkets & MarketingNorth AmericaOncologyOno PharmaceuticalOnyx PharmaceuticalsPharmaceuticalpomalidomide

Bayer's Stivarga races to FDA approval on the heels of Zaltrap


The earlier than expected US Food and Drug Administration approval of German drug major Bayer's (BAYN:…

BayerBiotechnologyMarkets & MarketingNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalregorafenibRegulationSanofiStivargaZaltrap

Back to top